Skip to main content
. 2019 Dec 2;2019:1389653. doi: 10.1155/2019/1389653

Table 1.

The correlations between lncRNA GATA3-AS1 expression and clinicopathologic variables in patients with hepatocellular carcinoma.

Variables Cases GATA3-AS1 χ 2 P
Low High
Gender
 Male 51 19 32 0.442 0.506
 Female 29 13 16

Age (years)
 <55 35 17 18 1.905 0.168
 ≥55 45 15 30

Tumor size (cm)
 <5 26 16 10 7.445 0.006
 ≥5 54 16 38

Differentiation
 Low 46 17 29 1.838 0.372
 Moderate 29 14 15
 High 5 1 4

Liver cirrhosis
 No 23 9 14 0.010 0.920
 Yes 57 23 34

Lymph node metastasis
 No 41 25 16 14.626 <0.001
 Yes 39 7 32

Venous invasion
 No 18 10 8 2.342 0.126
 Yes 62 22 40

TNM stage
 I + II 27 17 10 8.954 0.003
 III + IV 53 15 38

LncRNA: long noncoding RNA, GATA3-AS1: GATA3 antisense RNA 1. P < 0.05.